Cytta Competitors

CYCA Stock

USD 0.02 0.01 20.00%

Cytta Corp competes with Cambium Networks, Ceragon Networks, KVH Industries, Knowles Cor, and AudioCodes; as well as few others. The company conducts business under Health Care Technology sector and is part of Health Care industry. Analyzing Cytta Corp competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Cytta Corp to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Cytta Corp Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Cytta Corp competition on your existing holdings.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytta Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

Hype

Prediction

Low	Estimated	High
0.00	0.02	9.38

Details

Intrinsic

Valuation

Low	Real	High
0.00	0.02	9.38

Details

Cytta Corp Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Cytta Corp and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Cytta and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Cytta Corp does not affect the price movement of the other competitor.

	CMBM	CRNT	KVHI	KN	AUDC	BOXL	SYTA	WTT	MINM	CLRO
CMBM		-0.57	-0.61	-0.63	0.36	0.22	0.12	-0.72	0.58	0.48	CMBM
CRNT	-0.57		0.94	0.81	0.13	-0.53	-0.58	0.48	-0.29	-0.41	CRNT
KVHI	-0.61	0.94		0.77	0.12	-0.58	-0.67	0.4	-0.24	-0.4	KVHI
KN	-0.63	0.81	0.77		-0.23	-0.13	-0.39	0.59	-0.46	-0.49	KN
AUDC	0.36	0.13	0.12	-0.23		-0.34	-0.31	-0.44	0.32	0.46	AUDC
BOXL	0.22	-0.53	-0.58	-0.13	-0.34		0.47	-0.06	-0.05	0.3	BOXL
SYTA	0.12	-0.58	-0.67	-0.39	-0.31	0.47		0.23	-0.02	0.01	SYTA
WTT	-0.72	0.48	0.4	0.59	-0.44	-0.06	0.23		-0.49	-0.55	WTT
MINM	0.58	-0.29	-0.24	-0.46	0.32	-0.05	-0.02	-0.49		0.41	MINM
CLRO	0.48	-0.41	-0.4	-0.49	0.46	0.3	0.01	-0.55	0.41		CLRO
	CMBM	CRNT	KVHI	KN	AUDC	BOXL	SYTA	WTT	MINM	CLRO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

High positive correlations

KVHI	+ 0.94	CRNT
KN	+ 0.81	CRNT
KN	+ 0.77	KVHI
WTT	+ 0.59	KN
MINM	+ 0.58	CMBM
CLRO	+ 0.48	CMBM

High negative correlations

WTT	- 0.72	CMBM
SYTA	- 0.67	KVHI
KN	- 0.63	CMBM
KVHI	- 0.61	CMBM
BOXL	- 0.58	KVHI
SYTA	- 0.58	CRNT

Risk-Adjusted Indicators

There is a big difference between Cytta OTC Stock performing well and Cytta Corp OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cytta Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CMBM	3.96	(1.15)	0.00	(0.79)	0.00	0.00	6.29	(11.02)	21.89
CRNT	2.84	0.82	0.26	0.83	2.22	(3.34)	9.77	(3.90)	23.50
KVHI	1.63	0.31	0.15	0.81	1.43	(2.08)	4.38	(2.74)	10.42
KN	1.43	0.08	0.10	0.13	1.35	(1.72)	2.67	(2.38)	12.11
AUDC	1.88	0.03	0.00	0.05	0.00	0.00	4.39	(2.80)	20.39
BOXL	3.09	(0.27)	0.00	(0.01)	0.00	0.00	5.00	(7.27)	35.39
SYTA	6.05	0.41	0.01	(0.05)	6.95	(9.67)	12.61	(8.43)	114.24
WTT	1.16	0.38	0.10	(0.28)	1.17	(2.12)	1.13	(1.21)	30.04
MINM	4.99	(0.23)	0.00	0.26	0.00	0.00	14.24	(8.42)	49.73
CLRO	2.29	(0.07)	0.00	(2.44)	0.00	0.00	5.17	(3.92)	15.87

Unable to evaluate fundamental data of [CMBM, CRNT, KVHI, KN, AUDC, BOXL, SYTA, WTT, MINM, CLRO, CASA, DZSI, HLIT, ADTN, CLFD] at this time. Please try again later

All Fundamental Data

Cytta Corp Competitive Analysis

The better you understand Cytta Corp competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Cytta Corp's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Cytta Corp's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	CYCA	CMBM	CRNT	KVHI	KN	AUDC	BOXL	SYTA	WTT	MINM
	20.00 0.02 Cytta	10.11 0.80 Cambium	1.05 4.79 Ceragon	2.41 5.66 KVH	0.05 19.82 Knowles	0.22 9.24 AudioCodes	2.27 0.43 Boxlight	4.88 0.86 Siyata	0.00 2.11 Wireless	23.70 2.61 Minim
Market Volatility (90 Days Market Risk)	Out of control	Unstable	Relatively risky	Somewhat reliable	Very steady	Somewhat reliable	Very risky	Dangerous	Very steady	Very steady
Market Performance (90 Days Performance)	Very Weak	Very Weak	Solid	Good	OK	Very Weak	Very Weak	Very Weak	Very Weak	Very Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Very High	Below Average	Very Small	Low	Very Low	Very Small	Below Average	Very High	Dangerous	Dangerous
Current Valuation (Equity Enterprise Value)	Over Valued	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued	Under Valued	Over Valued	Fairly Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Buy	Strong Buy	Buy	Strong Buy	Hold	Buy	Hold	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Strong Buy	Strong Buy	Buy	Strong Sell	Strong Sell	Strong Sell	Not Rated	Not Rated
Current Ratio	3.61	2.29	1.61	2.57	2.87	1.48	1.99	1.55	3.41	2.04
Net Asset	911.01 K	217.88 M	298.52 M	172.63 M	1.46 B	337.52 M	158.57 M	15.51 M	44.97 M	12.36 M
Profit Margin	N/A	-0.57	0.0287	-0.16	-0.26	0.0499	-0.27	-2.69	0.16	-1.05
EBITDA	(5 M)	(52.1 M)	30.25 M	(1.67 M)	98.9 M	18.53 M	(17.59 M)	(11.04 M)	(871 K)	(16.44 M)
Operating Margin	-829.72	-0.18	0.12	-0.0295	0.14	0.0809	0.0347	-2.28	-0.15	-1.41
Current Valuation	34.94 M	53.08 M	418.66 M	63.3 M	1.89 B	259.51 M	41.9 M	7.29 M	26.32 M	10.29 M
Price To Book	26.57	0.52	2.62	0.78	2.25	1.43	0.65	0.35	1.07	0.36
Retained Earnings	(7.33 M)	(64.6 M)	(275.19 M)	(1.7 M)	(375.8 M)	20.79 M	(104.28 M)	(90.75 M)	15.14 M	(92.47 M)
Current Asset	20 K	100.41 M	226.91 M	115.09 M	336.1 M	73.85 M	8.57 M	N/A	23.83 M	N/A
Five Year Return	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	2.8	N/A
Beta	0.73	0.98	1.36	0.6	1.42	0.87	1.32	1.09	0.93	2.91
Number Of Employees	13	625	1.05 K	325	7.1 K	950	228	23	68	43
Shares Outstanding	383.69 M	28.24 M	85.87 M	19.8 M	88.07 M	28.91 M	9.83 M	4.07 M	21.32 M	2.81 M
Cash Flow From Operations	(2.38 M)	(16.95 M)	30.89 M	2.53 M	122.7 M	14.89 M	11.58 M	(8.34 M)	(9.65 M)	4.85 M
Annual Yield	N/A	N/A	N/A	N/A	N/A	0.039	N/A	N/A	N/A	N/A
Total Debt	438.1 K	33.24 M	50.2 M	1.07 M	286.7 M	39.28 M	49.28 M	2.2 M	615 K	22.51 K
Return On Equity	-7.68	-1.13	0.0771	-0.13	0.0524	0.0666	-0.76	-3.29	-0.0658	-2.7
Z Score	-6.7	N/A	N/A	N/A	N/A	N/A	N/A	N/A	45.98	N/A
Return On Asset	-2.89	-0.22	0.0614	-0.0698	0.0329	0.0387	-0.0145	-0.43	-0.0437	-0.58
Book Value Per Share	0.001	1.55	1.57	7.34	8.8	6.19	1.73	306.3	1.88	-0.45
Number Of Shares Shorted	N/A	570.3 K	281.98 K	59.9 K	2.61 M	221.17 K	92.84 K	196.01 K	33.23 K	113.5 K
Current Liabilities	460 K	63.77 M	142.6 M	43.56 M	175.4 M	43.48 M	9.93 M	N/A	1.77 M	N/A
Total Asset	911.01 K	217.88 M	298.52 M	172.63 M	1.46 B	337.52 M	158.57 M	15.51 M	44.97 M	12.36 M
Debt To Equity	N/A	0.29	0.38	0.018	0.081	0.088	0.81	0.24	0.026	0.24
Short Ratio	N/A	6.17	0.29	1.17	4.72	2.13	1.55	0.02	0.24	0.06
Target Price	N/A	3.34	6.83	7.0	21.75	9.67	1.13	1915.2	2.25	8.75
Last Dividend Paid	N/A	N/A	N/A	N/A	N/A	0.18	N/A	N/A	N/A	N/A
Shares Owned By Institutions	N/A	78.43	17.2	59.98	98.07	52.36	5.67	1.0	32.2	2.06
Market Capitalization	15.35 M	22.66 M	411.32 M	111.96 M	1.75 B	269.91 M	4.23 M	3.5 M	45.41 M	9.85 M
Price To Earning	-0.29	12.53	12.96	4.2	50.47	19.64	-4.42	N/A	154.0	N/A
Price To Earnings To Growth	N/A	0.8	8.8	3.35	1.12	0.83	N/A	N/A	N/A	N/A
Price To Sales	1265.04	0.13	1.14	0.95	2.18	1.11	0.0258	0.44	0.76	0.57
Net Income	(5.1 M)	(77.42 M)	6.22 M	(15.42 M)	72.4 M	8.78 M	(39.16 M)	(12.93 M)	14.59 M	(17.63 M)
Earnings Per Share	-0.013	-3.54	0.21	-0.99	0.51	0.4	-3.18	65.55	-0.11	-8.1
Shares Owned By Insiders	29.32	3.9	20.4	37.6	1.93	22.66	5.8	N/A	7.8	59.7
Revenue	6.09 K	220.19 M	347.18 M	132.38 M	707.6 M	244.38 M	176.72 M	8.23 M	22.37 M	26.11 M
Working Capital	(440 K)	66.24 M	84.99 M	93.85 M	264.2 M	58.46 M	54.15 M	1.28 M	28.69 M	(844.93 K)
Cash And Equivalents	1.57 M	45.93 M	23.59 M	15.55 M	48.2 M	57.84 M	11.62 M	4.05 M	20.71 M	4.22 M
Cash Per Share	N/A	1.7	0.28	0.81	0.46	1.82	0.16	0.27	0.62	0.09
Gross Profit	6.09 K	145.14 M	93.06 M	52.67 M	308.5 M	178.78 M	66.36 M	(1.22 M)	25.09 M	11.93 M
Day Typical Price	0.0203	0.83	4.8	5.7	19.74	9.24	0.43	0.86	2.11	2.48
Accumulation Distribution	0.0476	0.15	0.0526	0.0293	0.0131	0.0225	0.0682	0.14	0.0047	0.35
Market Facilitation Index	0.001	0.14	0.26	0.17	0.26	0.21	0.03	0.13	0.01	1.02
Daily Balance Of Power	(5.00)	(0.64)	0.1923	(0.82)	(0.04)	(0.1)	(0.33)	0.3077	N/A	0.4902
Period Momentum Indicator	(0.01)	(0.09)	0.05	(0.14)	(0.01)	(0.02)	(0.01)	0.04	N/A	0.5
Rate Of Daily Change	0.8	0.9	1.01	0.98	1.0	1.0	0.98	1.05	1.0	1.24
Day Median Price	0.0205	0.85	4.81	5.72	19.7	9.24	0.43	0.86	2.12	2.41
Price Action Indicator	(0)	(0.1)	0.005	(0.12)	0.12	(0.01)	N/A	0.025	(0.01)	0.45
Coefficient Of Variation	10415.36	(499.31)	467.5	585.13	739.83	(8,058)	(33,255)	7572.28	1302.02	(2,175)
Mean Deviation	6.87	3.96	2.84	1.63	1.43	1.88	3.09	6.05	1.16	4.99
Jensen Alpha	(0.03)	(1.15)	0.8177	0.3142	0.0833	0.031	(0.27)	0.4056	0.3775	(0.23)
Total Risk Alpha	(1.17)	(1.66)	0.3786	0.0892	0.0113	(0.40)	(0.64)	(1.39)	(0.19)	(1.29)
Sortino Ratio	(0.0003)	N/A	0.2578	0.1478	0.1038	N/A	N/A	0.0084	0.1044	N/A
Downside Variance	130.8	N/A	10.3	3.17	2.49	N/A	N/A	57.6	3.48	N/A
Standard Deviation	10.12	5.1	4.34	2.13	1.95	2.86	4.93	12.4	3.84	7.51
Kurtosis	1.18	0.2361	2.71	0.0972	4.25	7.5	4.74	30.17	54.03	5.44
Potential Upside	15.0	6.29	9.77	4.38	2.67	4.39	5.0	12.61	1.13	14.24
Treynor Ratio	0.0648	(0.79)	0.83	0.8115	0.1341	0.0536	(0.01)	(0.05)	(0.28)	0.2621
Maximum Drawdown	50.43	21.89	23.5	10.42	12.11	20.39	35.39	114.24	30.04	49.73
Variance	102.37	25.98	18.79	4.52	3.81	8.18	24.31	153.66	14.74	56.45
Market Risk Adjusted Performance	0.0748	(0.78)	0.84	0.8215	0.1441	0.0636	0.001	(0.04)	(0.27)	0.2721
Risk Adjusted Performance	0.0162	(0.14)	0.1634	0.1305	0.1043	(0)	0.0063	0.019	0.0638	(0.02)
Skewness	0.5406	(0.61)	1.4	0.4192	1.08	(1.00)	0.2281	4.32	6.91	1.38
Semi Deviation	7.99	N/A	2.22	1.43	1.35	N/A	N/A	6.95	1.17	N/A
Information Ratio	(0.0003)	(0.22)	0.1908	0.1238	0.0839	(0.05)	(0.02)	0.0051	0.0507	(0.06)
Value At Risk	(16.67)	(11.02)	(3.90)	(2.74)	(2.38)	(2.80)	(7.27)	(8.43)	(1.21)	(8.42)
Expected Short fall	(11.44)	N/A	(3.34)	(2.08)	(1.72)	N/A	N/A	(9.67)	(2.12)	N/A
Downside Deviation	11.44	N/A	3.21	1.78	1.58	N/A	N/A	7.59	1.87	N/A
Semi Variance	63.85	N/A	4.94	2.06	1.82	N/A	N/A	48.27	1.36	N/A

Cytta Corp Competition Performance Charts

Five steps to successful analysis of Cytta Corp Competition

Cytta Corp's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Cytta Corp in relation to its competition. Cytta Corp's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Cytta Corp in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Cytta Corp's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Cytta Corp, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Cytta Corp position

In addition to having Cytta Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Tips ETFs Thematic Idea Now

Tips ETFs

ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Tips ETFs theme has 41 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tips ETFs Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Cytta OTC Stock

Cytta Corp financial ratios help investors to determine whether Cytta OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cytta with respect to the benefits of owning Cytta Corp security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC